rs4774472

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001018005.2(TPM1):​c.564-152C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.808 in 840,410 control chromosomes in the GnomAD database, including 275,667 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.80 ( 48569 hom., cov: 31)
Exomes 𝑓: 0.81 ( 227098 hom. )

Consequence

TPM1
NM_001018005.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0850

Publications

8 publications found
Variant links:
Genes affected
TPM1 (HGNC:12010): (tropomyosin 1) This gene is a member of the tropomyosin family of highly conserved, widely distributed actin-binding proteins involved in the contractile system of striated and smooth muscles and the cytoskeleton of non-muscle cells. Tropomyosin is composed of two alpha-helical chains arranged as a coiled-coil. It is polymerized end to end along the two grooves of actin filaments and provides stability to the filaments. The encoded protein is one type of alpha helical chain that forms the predominant tropomyosin of striated muscle, where it also functions in association with the troponin complex to regulate the calcium-dependent interaction of actin and myosin during muscle contraction. In smooth muscle and non-muscle cells, alternatively spliced transcript variants encoding a range of isoforms have been described. Mutations in this gene are associated with type 3 familial hypertrophic cardiomyopathy and dilated cardiomyopathy 1Y. [provided by RefSeq, Jun 2022]
TPM1 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
  • dilated cardiomyopathy 1Y
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • left ventricular noncompaction
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 15-63061561-C-A is Benign according to our data. Variant chr15-63061561-C-A is described in ClinVar as Benign. ClinVar VariationId is 1179789.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.973 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TPM1NM_001018005.2 linkc.564-152C>A intron_variant Intron 5 of 9 ENST00000403994.9 NP_001018005.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TPM1ENST00000403994.9 linkc.564-152C>A intron_variant Intron 5 of 9 1 NM_001018005.2 ENSP00000385107.4

Frequencies

GnomAD3 genomes
AF:
0.797
AC:
121113
AN:
152032
Hom.:
48513
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.766
Gnomad AMI
AF:
0.797
Gnomad AMR
AF:
0.842
Gnomad ASJ
AF:
0.759
Gnomad EAS
AF:
0.995
Gnomad SAS
AF:
0.876
Gnomad FIN
AF:
0.756
Gnomad MID
AF:
0.696
Gnomad NFE
AF:
0.793
Gnomad OTH
AF:
0.787
GnomAD4 exome
AF:
0.810
AC:
557820
AN:
688260
Hom.:
227098
Cov.:
9
AF XY:
0.812
AC XY:
297478
AN XY:
366574
show subpopulations
African (AFR)
AF:
0.756
AC:
13852
AN:
18316
American (AMR)
AF:
0.885
AC:
33973
AN:
38376
Ashkenazi Jewish (ASJ)
AF:
0.762
AC:
15800
AN:
20722
East Asian (EAS)
AF:
0.997
AC:
34891
AN:
34990
South Asian (SAS)
AF:
0.858
AC:
57382
AN:
66868
European-Finnish (FIN)
AF:
0.761
AC:
32152
AN:
42226
Middle Eastern (MID)
AF:
0.696
AC:
2922
AN:
4196
European-Non Finnish (NFE)
AF:
0.792
AC:
338679
AN:
427460
Other (OTH)
AF:
0.802
AC:
28169
AN:
35106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
5627
11254
16881
22508
28135
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3730
7460
11190
14920
18650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.797
AC:
121228
AN:
152150
Hom.:
48569
Cov.:
31
AF XY:
0.798
AC XY:
59329
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.766
AC:
31780
AN:
41478
American (AMR)
AF:
0.843
AC:
12891
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.759
AC:
2635
AN:
3472
East Asian (EAS)
AF:
0.995
AC:
5154
AN:
5178
South Asian (SAS)
AF:
0.876
AC:
4217
AN:
4814
European-Finnish (FIN)
AF:
0.756
AC:
8004
AN:
10586
Middle Eastern (MID)
AF:
0.711
AC:
209
AN:
294
European-Non Finnish (NFE)
AF:
0.793
AC:
53949
AN:
68008
Other (OTH)
AF:
0.788
AC:
1662
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1261
2522
3783
5044
6305
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
878
1756
2634
3512
4390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.790
Hom.:
6153
Bravo
AF:
0.800
Asia WGS
AF:
0.925
AC:
3216
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.73
DANN
Benign
0.37
PhyloP100
-0.085
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4774472; hg19: chr15-63353760; API